nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—myometrium—ovarian cancer	0.0842	0.102	CbGeAlD
Tofisopam—PDE2A—uterine cervix—ovarian cancer	0.0655	0.0793	CbGeAlD
Tofisopam—PDE2A—decidua—ovarian cancer	0.0624	0.0756	CbGeAlD
Tofisopam—PDE10A—decidua—ovarian cancer	0.0624	0.0756	CbGeAlD
Tofisopam—PDE2A—uterus—ovarian cancer	0.0546	0.0661	CbGeAlD
Tofisopam—PDE2A—female reproductive system—ovarian cancer	0.0491	0.0594	CbGeAlD
Tofisopam—PDE10A—female gonad—ovarian cancer	0.0447	0.0541	CbGeAlD
Tofisopam—PDE2A—vagina—ovarian cancer	0.0444	0.0537	CbGeAlD
Tofisopam—PDE4A—decidua—ovarian cancer	0.0429	0.052	CbGeAlD
Tofisopam—CYP3A4—Topotecan—ovarian cancer	0.0422	0.354	CbGbCtD
Tofisopam—PDE10A—testis—ovarian cancer	0.0396	0.048	CbGeAlD
Tofisopam—PDE2A—testis—ovarian cancer	0.0396	0.048	CbGeAlD
Tofisopam—PDE4A—female gonad—ovarian cancer	0.0307	0.0372	CbGeAlD
Tofisopam—CYP3A4—Vinorelbine—ovarian cancer	0.0298	0.25	CbGbCtD
Tofisopam—PDE2A—lymph node—ovarian cancer	0.0287	0.0348	CbGeAlD
Tofisopam—PDE10A—lymph node—ovarian cancer	0.0287	0.0348	CbGeAlD
Tofisopam—PDE3A—female reproductive system—ovarian cancer	0.0279	0.0338	CbGeAlD
Tofisopam—PDE4A—testis—ovarian cancer	0.0273	0.033	CbGeAlD
Tofisopam—PDE3A—female gonad—ovarian cancer	0.0254	0.0308	CbGeAlD
Tofisopam—PDE3A—testis—ovarian cancer	0.0225	0.0273	CbGeAlD
Tofisopam—CYP3A4—Paclitaxel—ovarian cancer	0.0209	0.175	CbGbCtD
Tofisopam—PDE4A—lymph node—ovarian cancer	0.0198	0.0239	CbGeAlD
Tofisopam—PDE3A—lymph node—ovarian cancer	0.0163	0.0198	CbGeAlD
Tofisopam—CYP3A4—Docetaxel—ovarian cancer	0.0151	0.127	CbGbCtD
Tofisopam—CYP3A4—Doxorubicin—ovarian cancer	0.0113	0.0945	CbGbCtD
Tofisopam—Colchicine—ABCB1—ovarian cancer	0.00985	0.691	CrCbGaD
Tofisopam—CYP3A4—female reproductive system—ovarian cancer	0.00895	0.0108	CbGeAlD
Tofisopam—Verapamil—ABCB1—ovarian cancer	0.00441	0.309	CrCbGaD
Tofisopam—PDE10A—Hemostasis—KRAS—ovarian cancer	9.22e-05	0.00226	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PPP2R1A—ovarian cancer	9.19e-05	0.00225	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PPP2R1A—ovarian cancer	9.16e-05	0.00225	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PIK3CD—ovarian cancer	9.15e-05	0.00224	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—AKT1—ovarian cancer	9.13e-05	0.00224	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CAV1—ovarian cancer	8.91e-05	0.00218	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PIK3CB—ovarian cancer	8.78e-05	0.00215	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ESR1—ovarian cancer	8.58e-05	0.0021	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PIK3CA—ovarian cancer	8.47e-05	0.00208	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—YAP1—ovarian cancer	8.45e-05	0.00207	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6ST—ovarian cancer	8.44e-05	0.00207	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL8—ovarian cancer	8.44e-05	0.00207	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—XIAP—ovarian cancer	8.28e-05	0.00203	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—YAP1—ovarian cancer	8.22e-05	0.00202	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—ovarian cancer	8.19e-05	0.00201	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PIK3CB—ovarian cancer	8.19e-05	0.00201	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APC—ovarian cancer	8.11e-05	0.00199	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CG—ovarian cancer	8.11e-05	0.00199	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—NRAS—ovarian cancer	8.11e-05	0.00199	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SMARCA4—ovarian cancer	8.07e-05	0.00198	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2—ovarian cancer	8.06e-05	0.00198	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—XIAP—ovarian cancer	8.05e-05	0.00198	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PIK3CB—ovarian cancer	7.97e-05	0.00196	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EREG—ovarian cancer	7.88e-05	0.00193	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SMARCA4—ovarian cancer	7.85e-05	0.00192	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HRAS—ovarian cancer	7.84e-05	0.00192	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAPK3—ovarian cancer	7.77e-05	0.00191	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL8—ovarian cancer	7.66e-05	0.00188	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EREG—ovarian cancer	7.66e-05	0.00188	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2—ovarian cancer	7.52e-05	0.00184	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAPK1—ovarian cancer	7.39e-05	0.00181	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EGFR—ovarian cancer	7.39e-05	0.00181	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PGR—ovarian cancer	7.38e-05	0.00181	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2—ovarian cancer	7.32e-05	0.0018	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TERT—ovarian cancer	7.3e-05	0.00179	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PGR—ovarian cancer	7.18e-05	0.00176	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CD—ovarian cancer	7.13e-05	0.00175	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PIK3CA—ovarian cancer	7.06e-05	0.00173	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—KRAS—ovarian cancer	6.98e-05	0.00171	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CG—ovarian cancer	6.94e-05	0.0017	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—AKT1—ovarian cancer	6.92e-05	0.0017	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PARP1—ovarian cancer	6.86e-05	0.00168	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.8e-05	0.00167	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CG—ovarian cancer	6.75e-05	0.00166	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CAV1—ovarian cancer	6.75e-05	0.00166	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.7e-05	0.00164	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PARP1—ovarian cancer	6.67e-05	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6ST—ovarian cancer	6.56e-05	0.00161	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ESR1—ovarian cancer	6.5e-05	0.0016	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PIK3CA—ovarian cancer	6.41e-05	0.00157	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6ST—ovarian cancer	6.4e-05	0.00157	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VEGFA—ovarian cancer	6.39e-05	0.00157	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6ST—ovarian cancer	6.38e-05	0.00157	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NRAS—ovarian cancer	6.31e-05	0.00155	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CG—ovarian cancer	6.31e-05	0.00155	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB2—ovarian cancer	6.3e-05	0.00154	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MTOR—ovarian cancer	6.22e-05	0.00152	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CB—ovarian cancer	6.22e-05	0.00152	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APC—ovarian cancer	6.15e-05	0.00151	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CG—ovarian cancer	6.15e-05	0.00151	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—NRAS—ovarian cancer	6.15e-05	0.00151	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CG—ovarian cancer	6.13e-05	0.0015	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CD—ovarian cancer	6.1e-05	0.0015	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MAPK3—ovarian cancer	6.05e-05	0.00148	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL8—ovarian cancer	5.97e-05	0.00146	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CD—ovarian cancer	5.94e-05	0.00146	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HRAS—ovarian cancer	5.93e-05	0.00146	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAPK3—ovarian cancer	5.89e-05	0.00144	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN1B—ovarian cancer	5.83e-05	0.00143	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AKT1—ovarian cancer	5.77e-05	0.00142	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MAPK1—ovarian cancer	5.75e-05	0.00141	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CASP3—ovarian cancer	5.72e-05	0.0014	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2—ovarian cancer	5.71e-05	0.0014	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—ovarian cancer	5.68e-05	0.00139	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAPK1—ovarian cancer	5.6e-05	0.00137	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EGFR—ovarian cancer	5.6e-05	0.00137	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCND1—ovarian cancer	5.57e-05	0.00136	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PPP2R1A—ovarian cancer	5.57e-05	0.00136	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CD—ovarian cancer	5.54e-05	0.00136	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CTNNB1—ovarian cancer	5.51e-05	0.00135	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—KRAS—ovarian cancer	5.43e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PPP2R1A—ovarian cancer	5.41e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CD—ovarian cancer	5.4e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—ovarian cancer	5.4e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CD—ovarian cancer	5.39e-05	0.00132	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTEN—ovarian cancer	5.37e-05	0.00132	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PIK3CA—ovarian cancer	5.35e-05	0.00131	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CB—ovarian cancer	5.32e-05	0.0013	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—KRAS—ovarian cancer	5.29e-05	0.0013	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AKT1—ovarian cancer	5.24e-05	0.00129	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CB—ovarian cancer	5.18e-05	0.00127	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL8—ovarian cancer	5.11e-05	0.00125	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PIK3CA—ovarian cancer	4.99e-05	0.00122	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL8—ovarian cancer	4.97e-05	0.00122	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2—ovarian cancer	4.89e-05	0.0012	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PIK3CA—ovarian cancer	4.86e-05	0.00119	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VEGFA—ovarian cancer	4.85e-05	0.00119	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CB—ovarian cancer	4.83e-05	0.00118	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—ovarian cancer	4.83e-05	0.00118	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—STAT3—ovarian cancer	4.8e-05	0.00118	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NRAS—ovarian cancer	4.79e-05	0.00118	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB2—ovarian cancer	4.77e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2—ovarian cancer	4.75e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CB—ovarian cancer	4.71e-05	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MTOR—ovarian cancer	4.71e-05	0.00116	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CB—ovarian cancer	4.7e-05	0.00115	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL8—ovarian cancer	4.64e-05	0.00114	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HRAS—ovarian cancer	4.62e-05	0.00113	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK3—ovarian cancer	4.59e-05	0.00113	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL8—ovarian cancer	4.53e-05	0.00111	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL8—ovarian cancer	4.52e-05	0.00111	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HRAS—ovarian cancer	4.5e-05	0.0011	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—ovarian cancer	4.46e-05	0.00109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—ovarian cancer	4.44e-05	0.00109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TERT—ovarian cancer	4.42e-05	0.00108	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1B—ovarian cancer	4.42e-05	0.00108	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AKT1—ovarian cancer	4.37e-05	0.00107	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK1—ovarian cancer	4.37e-05	0.00107	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—ovarian cancer	4.37e-05	0.00107	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CASP3—ovarian cancer	4.33e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—ovarian cancer	4.33e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—ovarian cancer	4.32e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—ovarian cancer	4.3e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TERT—ovarian cancer	4.3e-05	0.00105	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCND1—ovarian cancer	4.22e-05	0.00103	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CTNNB1—ovarian cancer	4.18e-05	0.00102	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NME2—ovarian cancer	4.14e-05	0.00102	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KRAS—ovarian cancer	4.12e-05	0.00101	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—ovarian cancer	4.09e-05	0.001	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CAV1—ovarian cancer	4.09e-05	0.001	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—AKT1—ovarian cancer	4.08e-05	0.001	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—ovarian cancer	4.07e-05	0.000998	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CAV1—ovarian cancer	3.98e-05	0.000976	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AKT1—ovarian cancer	3.97e-05	0.000974	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ESR1—ovarian cancer	3.94e-05	0.000966	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6ST—ovarian cancer	3.88e-05	0.000951	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ESR1—ovarian cancer	3.83e-05	0.00094	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CA—ovarian cancer	3.79e-05	0.000929	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6ST—ovarian cancer	3.77e-05	0.000925	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APC—ovarian cancer	3.72e-05	0.000913	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CG—ovarian cancer	3.72e-05	0.000913	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—NRAS—ovarian cancer	3.72e-05	0.000913	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—ovarian cancer	3.68e-05	0.000902	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—ovarian cancer	3.67e-05	0.000899	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—STAT3—ovarian cancer	3.64e-05	0.000893	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NRAS—ovarian cancer	3.63e-05	0.000891	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APC—ovarian cancer	3.62e-05	0.000889	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CG—ovarian cancer	3.62e-05	0.000889	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—NRAS—ovarian cancer	3.62e-05	0.000889	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK3—ovarian cancer	3.57e-05	0.000875	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HRAS—ovarian cancer	3.51e-05	0.00086	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK3—ovarian cancer	3.48e-05	0.000853	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK3—ovarian cancer	3.47e-05	0.000851	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK1—ovarian cancer	3.39e-05	0.000832	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—ovarian cancer	3.39e-05	0.000832	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—ovarian cancer	3.38e-05	0.00083	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—ovarian cancer	3.36e-05	0.000823	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK1—ovarian cancer	3.31e-05	0.000812	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—ovarian cancer	3.31e-05	0.000811	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK1—ovarian cancer	3.3e-05	0.00081	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—ovarian cancer	3.3e-05	0.00081	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CD—ovarian cancer	3.27e-05	0.000803	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.24e-05	0.000795	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—KRAS—ovarian cancer	3.21e-05	0.000786	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CD—ovarian cancer	3.19e-05	0.000781	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.16e-05	0.000774	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KRAS—ovarian cancer	3.13e-05	0.000767	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—KRAS—ovarian cancer	3.12e-05	0.000765	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AKT1—ovarian cancer	3.1e-05	0.000759	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CA—ovarian cancer	2.95e-05	0.000722	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB2—ovarian cancer	2.89e-05	0.000709	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CA—ovarian cancer	2.87e-05	0.000704	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CA—ovarian cancer	2.87e-05	0.000703	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MTOR—ovarian cancer	2.85e-05	0.0007	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CB—ovarian cancer	2.85e-05	0.0007	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB2—ovarian cancer	2.81e-05	0.00069	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—ovarian cancer	2.78e-05	0.000681	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MTOR—ovarian cancer	2.78e-05	0.000681	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CB—ovarian cancer	2.78e-05	0.000681	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL8—ovarian cancer	2.74e-05	0.000673	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HRAS—ovarian cancer	2.72e-05	0.000668	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1B—ovarian cancer	2.68e-05	0.000657	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYTB—ovarian cancer	2.67e-05	0.000655	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL8—ovarian cancer	2.67e-05	0.000654	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HRAS—ovarian cancer	2.66e-05	0.000652	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HRAS—ovarian cancer	2.65e-05	0.00065	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AKT1—ovarian cancer	2.65e-05	0.00065	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CASP3—ovarian cancer	2.63e-05	0.000644	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—ovarian cancer	2.62e-05	0.000643	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—ovarian cancer	2.61e-05	0.00064	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1B—ovarian cancer	2.61e-05	0.000639	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AKT1—ovarian cancer	2.58e-05	0.000632	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCND1—ovarian cancer	2.56e-05	0.000627	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CASP3—ovarian cancer	2.55e-05	0.000626	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—ovarian cancer	2.55e-05	0.000625	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—ovarian cancer	2.54e-05	0.000624	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—ovarian cancer	2.54e-05	0.000622	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CTNNB1—ovarian cancer	2.53e-05	0.000621	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCND1—ovarian cancer	2.49e-05	0.00061	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—ovarian cancer	2.48e-05	0.000608	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—ovarian cancer	2.47e-05	0.000605	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CTNNB1—ovarian cancer	2.46e-05	0.000604	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—ovarian cancer	2.41e-05	0.000592	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AKT1—ovarian cancer	2.41e-05	0.00059	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—ovarian cancer	2.4e-05	0.000588	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AKT1—ovarian cancer	2.35e-05	0.000575	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AKT1—ovarian cancer	2.34e-05	0.000574	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.33e-05	0.000572	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.33e-05	0.000572	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—ovarian cancer	2.23e-05	0.000546	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—STAT3—ovarian cancer	2.21e-05	0.000541	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NRAS—ovarian cancer	2.2e-05	0.00054	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—ovarian cancer	2.17e-05	0.000531	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—STAT3—ovarian cancer	2.15e-05	0.000526	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NRAS—ovarian cancer	2.14e-05	0.000525	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK3—ovarian cancer	2.11e-05	0.000517	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK3—ovarian cancer	2.05e-05	0.000503	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—ovarian cancer	2.05e-05	0.000503	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK1—ovarian cancer	2.01e-05	0.000492	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—ovarian cancer	2e-05	0.000492	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—ovarian cancer	1.99e-05	0.000489	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK1—ovarian cancer	1.95e-05	0.000478	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—ovarian cancer	1.95e-05	0.000478	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KRAS—ovarian cancer	1.89e-05	0.000464	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KRAS—ovarian cancer	1.84e-05	0.000452	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CA—ovarian cancer	1.74e-05	0.000427	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CA—ovarian cancer	1.69e-05	0.000415	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—ovarian cancer	1.68e-05	0.000413	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—ovarian cancer	1.64e-05	0.000402	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HRAS—ovarian cancer	1.61e-05	0.000395	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HRAS—ovarian cancer	1.57e-05	0.000384	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—YAP1—ovarian cancer	1.57e-05	0.000384	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—ovarian cancer	1.54e-05	0.000378	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—ovarian cancer	1.5e-05	0.000368	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT1—ovarian cancer	1.42e-05	0.000349	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT1—ovarian cancer	1.38e-05	0.000339	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FASN—ovarian cancer	1.28e-05	0.000313	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.26e-05	0.000308	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.21e-05	0.000297	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.16e-05	0.000285	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.03e-05	0.000253	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.57e-06	0.000235	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TYMS—ovarian cancer	9.4e-06	0.00023	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAV1—ovarian cancer	7.57e-06	0.000186	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.9e-06	0.000169	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.06e-06	0.000149	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.29e-06	0.00013	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—ovarian cancer	4.57e-06	0.000112	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.22e-06	7.9e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AKT1—ovarian cancer	2.63e-06	6.46e-05	CbGpPWpGaD
